Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2012; 18(15): 1753-1764
Published online Apr 21, 2012. doi: 10.3748/wjg.v18.i15.1753
Figure 2
Figure 2 Effects of tectorigenin on the viability of HepG2 (A) and L02 cells (B). Cells were treated for 12, 24 and 48 h with tectorigenin at 2.5, 5, 10, 15, 20, 30 and 40 mg/L, respectively, followed by assessing the cell viability relative to that of untreated cells (control). Bars represent mean ± SD.